DrMaurice Swanson

Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center

The molecular basis of 7SK RNA methylation in non-small cell lung cancer

Understanding and targeting common mechanisms of myotonic dystrophy types 1 and 2 using novel repeat expansion mouse models

Mouse Dmpk CTG expansion knock in models for myotonic dystrophy (MDA 1070134)

Therapeutic strategies for microsatellite expansion diseases using RNA-targeting

Regenerative failure in myotonic dystrophy: pathomechanisms and insights from a novel model of improved regeneration

Mouse humanized models for myotonic dystrophy type 1 for therapy development

Brain Choroid Plexus Dysregulation and Cerebral Atrophy in DM1

Provenance Initiatives Fund at the Center for NeuroGenetics

Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center (Administrative Core)

RNA Processing-Mediated Mechanisms of CNS Dysfunction in Myotonic Dystrophy

International Myotonic Dystrophy Consortium Meeting IDMC-12

Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center (Project 3 Preclinical Model and Therapies for DM2).

Senator Paul D. Wellstone Muscular dystrophy Speciallzed Research Center (Project 2 Disease Progress and Biomarkers) # #

Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center

Pre-mRNA Misprocessing in Myotonic Dystrophy and Amyotrophic Lateral Sclerosis

Congenital myotonic dystrophy:pathomechanism and therapeutic development

Therapeutic strategies for microsatellite expansion diseases using RNA-targeting CRISPR/Cas

Determining the factors that control dose-dependent splicing regulation by a master regulator

Novel Mouse Knockin Models for Myotonic Dystrophy

Molecular Characterization of ALS/FTD in a novel C9orf72 BAC mouse model.

Myotonic Dystrophy Type 2: Mouse Models, pathomechanism and therapy

Research Program MGOLD project 2

MBI Research Program MGOLD2

Myotonic Dystrophy: Molecular Pathophysiology and CNS Effects